Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
blulotus I am not sure. I am a fundamentalist which means I have little confidence in the technical charts. I have almost next to no confidence in a technical chart for a penny stock like TDCP. I have been investing in TDCP for over a year. Finally, the science has kicked in big time and companies like Boeing notice it. Getting a patent helps too. There are a lot of investors in below .04. That is where the problem is. That is why a bottom is hard to predict. I will say this. There was a lot of panic selling today which was great! That means that the class of investors who are in below .04 may have been scared and decided to jump ship. Don't panic blulotus. Just ride it out. I bought some more below .05 to average down. Good luck.
Why did TDCP tank today? The most likely reason is because TDCP had a lot of investors in below .04, and I mean a lot. When TDCP went up as fast as she did, many of these people did not sell. They stayed in and watch the stock rise to .10. Even now there are investors in below .01. Today, we went through a wash. Many of those who bought in during the last 6 months sold yesterday and today. In a half a sense, what happened to TDCP today was good. As long as those class of investors were around, those in below .04 or .01, they were a threat to the pps stability. They could have caused the stock to tank one month now or even later. Many of them are now gone and sold today to lock in profits. That is good. Those who bought in today and yesterday are in bed with us or most of us anyway. Aside from that, does anyone seriously believe TDCP will be at this price 90 days from now? or even at .10? I seriously doubt it. The underlying 3D product is too good. There are too many people interested in the new science TDCP has to offer. I am very exciting about this stock. I think a $1.00+ per share for TDCP by December is a real possibility.
I agree. I am thinking of buying more at the end of the day.
What we are experiencing is known as a "baptism of fire". This is the men get separated from the boys. Clearly, a lot of buyers at .04 and lower are bailing out which is just fine. The smart ones are holding on.
Anybody care to bet if she will break below .07 today? I hope not but if we close here, next week may be difficult--unless some more news comes out.
I bought more this morning and again just a few minutes ago.
What you have said is very true. As long as the spread between bid and ask is tight, the stock should not move sharply downward during a low volume period.
Would somebody please turn on the heater. We need more volume. ty.
ROFLOL
Good move 7Kevin, even if TDCP tanks today, stay in. The most important thing to remember is that TDCP has good science. Forget about the balance sheet, its the science that matters. Anykind of good news from Boeing etc. could send TDCP to the third heaven.
Are you thumbs today or thumbs down?
Volume is coming back nicely. Now she is moving.
JV, you might want to wait until after the reverse stock split before you buy. After the split, ADLS will drop more--somewhere around 50% or higher.
ribz, I am with you. Clearly, you could be right. If you are, I will not wait till cob to start drinking. lol.
It would have been nice if it closed at .08 but I will take .0799.
It did not close with a lot of panic selling. That's a good sign that tomorrow might be ok. I think tomorrow it will stay in this general area for awhile. Unless somebody wants to load up big, I think the days of 25%+ rises in the pps are over for now. Tomorrow will tell us lot.
I think all of those people who bought at .04 or lower had to shed their shares at some point. I think we just saw a lot of profit taking.
If it closes even or up a little today, it may stablize around the .07 .08 area and possibly start its upward big mo. What do you think? Will it go down below .07 tomorrow?
1estimator, I watched the video. And it made a lot of good points. But please remember, TDCP has a lot of interest not just from investors like you and me but big firms like Boeing. Thus, even with a correction, this stock will come back and go much higher. TDCP's 3D technology is a game changer. That is the single most important fact to remember. Thanks for sharing the video.
It looks like I was wrong about a correction for TDCP. Oh well.
I am far from proficient with technical stock charts but the RSI will say any stock is overbought or oversold if the stock moves 25%+. The RSI is not the best indicator. When the volume drops, then a correction might occur. Also, I think the reason TDCP has not had a major correction to date is because the stock was so low for so long, there may not be a correction until later. Somebody is buying big time. There has been a lot of profit taking already but you would never know it by the pps. Somebody wants this company bad.
Thank you for your responses to my question about big Institutional Investors. Has anybody heard of a good TP for TDCP? It may be too soon for an analyst to come up with one. From the way TDCP is behaving, it is possible that $1.00 by the end of the year is in the cards. Is that number wishful thinking? What do you think?
Can anybody tell if big Institutional Investors are buying TDCP?
Generally, they will not fool with a small penny stock like this but TDCP is holding a game changer technology in the 3D area. I cannot find out about Institutional Investors. I went to the Pink Sheets but they say nothing about it. Anybody know? I would be very grateful for your help.
Don't worry Jaws. If ILNS can pass this liquidity crisis and I think she will, .003 will look cheap. It will not take too much to get ILNS to move upward very very fast. I’ve been in your position dozens of times and came out smelling like a rose. Just ride it out.
I am amazed how well ILNS is holding up. I was expecting a much steeper decline. So far we only briefly hit my last buy price of .0015, and that was very briefly yesterday. The pps for ILNS suggests that a reverse split is NOT going to happen. GREAT!!
A reverse split is less likely as each day goes by.
A reverse split is less likely as each day goes by.
I am not sure about that. It seems to me that listed companies tell their investors ahead of time of the reverse split, which is what ILNS did and Citibank did earlier this week. I think few companies would do a reverse split without some kind of notice. Management knows that current common stockholders generally are hurt by the reverse split and thus they give notice.
Remember, ILNS fiscal year ends June 30th. That means the 3rd quarter ends March 31st.
Let's get our facts straight about the possible reverse split for ILNS. I admit a reverse split becomes less likely every day. If it is going to happen it must happen by March 31st, 2011. In 2009,ILNS said they intend to do a reverse split. LAST MONTH, ILNS said they intend to do the reverse split they said they were going to do in 2009, they will do it SOMETIME DURING THE 3RD QUARTER OF 2011. Read the most recent 10-Q dated FEBRUARY 22, 2011, from page 13:
“In December 2009, our shareholders approved a resolution authorizing the Company to amend its certificate of incorporation to effect a reverse split of the Company's outstanding common stock, pursuant to which any whole number of outstanding shares between, and including, fifteen and fifty would be combined into one share of common stock and to authorize the Company's Board of Directors to select and file one such amendment. Management intends to effectuate this reverse split during our third fiscal quarter.”
If I understand this paragraph correctly, we are in the third fiscal quarter now for ILNS. That means if a reverse split is going to occur it will happen in the immediate future. Naturally, a reverse split, if history is any guide, would adversely affect the current Common Stock holders. I don’t know if ILNS will or will not do a reverse split. Will they do what they said they intend to do? I checked the prior 10-Q’s and the Annual Financials (10/13/2010) and I could not find any discussion about a reverse split. Thus, this paragraph appears to be new. It is clear that ILNS is diluting the Common Stock. The 10-Q repeatedly states that Notes Holders and Preferred Stockholders are being paid-off with Common Stock. An orderly dilution of Common Stock to pay debt does not concern me. Small pharmaceuticals do it a lot. They have to. But a reverse split is a different matter. I have already taken the necessary steps to protect my gains in ILNS. As you know I am in at .0015. As soon as April 1, 2011 comes by I will reassess the situation. If no reverse split has occurred, it’s party time! If a reverse split has occurred, I will wait and watch what usually happens in a reverse split and buy after the decline is over. I have removed my TP of .20 from my Personal Profile. I believe ILNS is going to make me more money than any stock I have ever owned! We have the good fortune to be in on the ground floor with a company that offers new and exciting cures for Alzheimer’s disease. Good luck to all of you.
All true ulfahl.
I can’t deny that ILNS is diluting the stock a lot.
Nevertheless, I think this company has great value.
I am beginning to think they will not reverse split
the stock (now that I have said it–then watch it happen, lol.). Clearly, the clock is working against a reverse split. In any case, it is amazing how well ILNS is holding up given the
amount of dilution. One thing to remember, a lot of the
dilution is with stocks that are restricted. I think this is
why the pps for ILNS has not tanked. There will come a time
when ILNS will not be diluted and when there will be no danger of
a reverse split–that is when ILNS will fly like an eagle. I know
I would be happy with a pps for ILNS between .15 and .20.
I agree Jonah. Unless something intervenes soon--like a new patent issue to ILNS or a buy out--this coming week I expect ILNS to slowly drift downward or stay in this area. I sold my last shares in ILNS earlier this week at .002. I am very concerned about a reverse split. The last 10-Q in February 2011 said they were going to do it--but that remains to be seen. I put in a call to ILNS and I sent an email to them to try to find out if maybe they changed their minds about the reverse split. I feel a little naked not holding any shares in ILNS. If something big happens between now and March 31st, I'm in deep dudu--not holding any shares. ILNS's 3rd quarter ends March 31st, I plan to get back in on Friday, April 1st. The 10-Q said the reverse split will occur in the 3rd quarter--that's now. Will they???? I don't know. One thing I do know, this stock is going to make me and all of us lots and lots of money. Not only that but we are using our dollars to help people who are ill. If I find anything out about the reverse split from ILNS or from someone "in the know" I will share the info with everyone. Have a great week-end!!
Calm down. Take it easy. Take a deep breath and relax. May I recommend you listen to Charlie Pride for an hour. ROFLOL.
You made my case for me!!
You said:
"Back up to near $30 a share in 2005. Another fast hard plunge to $3 a share. Then all the way back up to $37 on the Bapineuzumab news. The stocks is now trading in the $7 area."
Do you understand what you just said? Do you understand that even if ILNS'S drugs don't work---lots of money is to be made!!!! What I want is movement in the stock price!!!! ILNS will go up and down, up and down again and again. I will need you when the stock goes up too much to bash it down again, so I can buy back in again. LOL. I like you, stick around.
My friend, I am afraid you do not understand ILNS and where its value lies. It does not matter whether ILNS actually conducts the trials or not. Again you are wrong. You do not understand this market at all. You are watching the balance sheet-big mistake. May I suggest you take two aspirins and call me tomorrow. LOL.
itsme, I think something good is cooking in the oven. Restanza is a great drug!!
wEaRe, I do not agree. The closer ILNS gets to the trials, the greater the chance of a buyer as well as stock appreciation. The further along in the trials, the greater the chance for a buy out and stock appreciation. I do not understand why you completely underestimate the value of the science ILNS offers to Alzheimer's disease. The company that cracks that disease will be worth billions and ILNS I think has the magic bullet. There is no doubt in my mind that Big Pharma is watching ILNS with a close eye. My friend, I am not sure you understand how to value pharmaceuticals. Forget about the balance sheet!! Look at the science!! No one disputes the value of ILNS's science products--except you. All public references to ILNS' patents are highly favorable. This stock will spike up dozens of times before ILNS hits Phase III. Don't be deceived by the price of the stock!! Don't let that number fool you into thinking there is nothing here. I think you are allowing the price of the stock influence your evaluation of the science ILNS holds. If you follow that kind of thinking, you should not be investing in pharmaceuticals. Try investing in other areas of the S&P. Markets are not always right, especially when it comes to bio stocks. I have seen more than a dozen bio stocks go from pennies to $1.00+ in the last two years. Some of them I owned, most I did not. This stock will be mucho grande higher in 6 to 18 months. Right now we have a little liquidity problem and a problem of whether there will be a reverse split--which I am still trying to find out about. I have already made 75% on my money in ILNS in this last spike up. There will be many more spikes in the years ahead. This is the stock that will keep on giving.
This might happen to ADLS.
Biotech Merger and Acquisition Activity Looks Poised to Surge
7:35a ET March 17, 2011 (Market Wire)
M&A activity in the healthcare sector has been on the upswing in recent quarters. Going forward, larger healthcare firms are expected to continue searching for smaller, more speculative companies which are focusing on specific treatments and specialties in the medical sector. Recent reports suggest that not only is Big Pharma active in acquisitions, but also larger biotech firms are showing willingness to utilize their large resource pools to acquire smaller firms in a race to diversify and to build their reach. The Bedford Report examines the outlook for companies in the Biotechnology Industry and provides research reports on Cell Therapeutics, Inc. (NASDAQ: CTIC) and Repros Therapeutics, Inc. (NASDAQ: RPRX). Access to the full company reports can be found at:
www.bedfordreport.com/2011-03-CTIC
www.bedfordreport.com/2011-03-RPRX
A recent report from Deal Search Online claims that while the biotech sector saw a 40 percent drop in the number of M&A deals last year, the 115 deals in 2010 amounted to $57.5 billion, a 21 percent increase over 2009. The report suggests that the last decade saw an increase in the amount of biotech deals, led in part by pharmaceutical companies seeking new blockbuster drugs to fill the void left by drugs coming off patent.
The Bedford Report releases regular market updates on the Healthcare Sector so investors can stay ahead of the crowd and make the best investment decisions to maximize their returns. Take a few minutes to register with us free at www.bedfordreport.com and get exclusive access to our numerous analyst reports and industry newsletters.
This might happen to ILNS.
Biotech Merger and Acquisition Activity Looks Poised to Surge
7:35a ET March 17, 2011 (Market Wire)
M&A activity in the healthcare sector has been on the upswing in recent quarters. Going forward, larger healthcare firms are expected to continue searching for smaller, more speculative companies which are focusing on specific treatments and specialties in the medical sector. Recent reports suggest that not only is Big Pharma active in acquisitions, but also larger biotech firms are showing willingness to utilize their large resource pools to acquire smaller firms in a race to diversify and to build their reach. The Bedford Report examines the outlook for companies in the Biotechnology Industry and provides research reports on Cell Therapeutics, Inc. (NASDAQ: CTIC) and Repros Therapeutics, Inc. (NASDAQ: RPRX). Access to the full company reports can be found at:
www.bedfordreport.com/2011-03-CTIC
www.bedfordreport.com/2011-03-RPRX
A recent report from Deal Search Online claims that while the biotech sector saw a 40 percent drop in the number of M&A deals last year, the 115 deals in 2010 amounted to $57.5 billion, a 21 percent increase over 2009. The report suggests that the last decade saw an increase in the amount of biotech deals, led in part by pharmaceutical companies seeking new blockbuster drugs to fill the void left by drugs coming off patent.
The Bedford Report releases regular market updates on the Healthcare Sector so investors can stay ahead of the crowd and make the best investment decisions to maximize their returns. Take a few minutes to register with us free at www.bedfordreport.com and get exclusive access to our numerous analyst reports and industry newsletters.
I hope you are right. I believe in Restanza. Our national security needs this drug. Plus, I am very hopeful that this stock will at the end of the day bring us big rewards. I must admit, I cannot find a July 31, 2011 for FDA approval for Restanza. However, Restanza is a post Phase III drug and I think it may be found on a different calendar. I am with you!! I am long on ADLS.
I don't agree Surf. I have already made money in ILNS. I sold a lot of shares on 3/8 at .0033 and more on 3/9 at .0026. I bought in at .0015. I made more than 75% on my money is less than 30 days. Of course, that is nothing. This stock has got good science. It is going places big time. You must however be patient.